Eric Bruno to lead North America commercial business at Dentsply Sirona
Eric Bruno has joined Dentsply Sirona as Senior Vice President of the North America Regional Commercial Organization. He is responsible…
Pharmaceuticals, Biotechnology and Life Sciences
Eric Bruno has joined Dentsply Sirona as Senior Vice President of the North America Regional Commercial Organization. He is responsible…
Global Medical cannabis leader expands dispensary footprint to Gainesville, one of Florida’s most densely populated metropolitan areas and provides update…
DUBLIN–(BUSINESS WIRE)–The “Cholera Vaccines Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s offering.…
DUBLIN–(BUSINESS WIRE)–The “Therapy Trends KOL Insight: Breast Cancer [2019]” report has been added to ResearchAndMarkets.com’s offering. What impact will the…
DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Excipients Market by Product (Organic Chemicals, Inorganic chemicals), Functionality (Fillers, Diluents, Coatings, Disintegrants), Formulation (Tablet, Capsule, Topical,…
The U.S. FDA has granted accelerated approval to Karyopharm Therapeutics’s Xpovio (selinexor) tablets in combination with the corticosteroid dexamethasone for the treatment of certain adult patients with relapsed refractory multiple myeloma (RRMM).
Swedish Cyxone has submitted an application to the CEC in Poland for permission to start a clinical phase IIb trial with Cyxone’s drug candidate Rabeximod in RA , marking the first regulatory step towards the initiation of the study.
Treatment emergent adverse events Grade 3 or higher were reported by 20 of 32 patients from the 50/60 dose pooled patient analysis; no patient reported Grade 3 or higher fatigue or peripheral neuropathy (primary endpoint) –
ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, this week said that the European Commission has granted Marketing Authorisation for HIV-1 infection treatment, Dovato.
DUBLIN–(BUSINESS WIRE)–The “The Impact of Drug Compounding on Pharma” report has been added to ResearchAndMarkets.com’s offering. Drug compounding meets unmet…